Biotech capital markets rebounded last year after a down year in 2018. The Nasdaq Biotechnology Index is up 24% for the year, but this is still about 5% below the gains by the rest of the market. Much of these gains are due to the perseverance of a biotech sector that delivered some transformational achievements
Editor’s note: This was part of CDR’s 2019 Pharmacy Outlook in the January 7 issue. For much of 2018, capital markets for biotech investment were strong. Some 53 biotech companies went public with more than $5.4 billion in funding, putting the biotech industry on track for the second-best year for IPOs in a decade. And
WASHINGTON — Dr. Scott Gottlieb has been sworn in as the new commissioner of the Food and Drug Administration. Gottlieb, nominated as FDA commissioner by President Donald Trump in March, took the helm as the FDA’s 23rd commissioner on Thursday after being confirmed by a vote of 57-42 in the Senate late Tuesday. He takes
WASHINGTON — New Jersey Gov. Chris Christie has approved legislation to create a pathway for the substitution of interchangeable biologic drugs, drawing praise from the Biotechnology Industry Organization (BIO) and BioNJ, a state biotechnology organization. Christie signed Assembly Bill 2477 into law on Monday, following unanimous passage in the New Jersey Senate and Assembly earlier
WASHINGTON — California Gov. Jerry Brown has approved legislation to create a pathway for the substitution of interchangeable biologic drugs, a move applauded by Biotechnology Industry Organization (BIO). This week, Brown signed Senate Bill 671 into law, following recent passage in both the California Senate and Assembly. The legislation authorizes a pharmacist filling a prescription
WASHINGTON — The Generic Pharmaceutical Association (GPhA) and its recently formed Biosimilars Council have praised the enactment of new legislation in five states to allow automatic substitution for Food and Drug Administration-approved interchangeable biologic products. Bills in Colorado (SB 71), Georgia (SB 51), Tennessee (SB 984), Utah (HB 279) and Washington (SB 5935) reflect core
